These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35900536)

  • 1. Expression of glucose transporter 1 (
    Vasudevan S; Mehta A; Sharma SK; Sharma A
    J Cancer Res Ther; 2022; 18(3):650-655. PubMed ID: 35900536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis.
    Shen YM; Arbman G; Olsson B; Sun XF
    Int J Biol Markers; 2011; 26(3):166-72. PubMed ID: 21786248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas.
    Jun YJ; Jang SM; Han HL; Lee KH; Jang KS; Paik SS
    World J Gastroenterol; 2011 Apr; 17(14):1866-73. PubMed ID: 21528061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
    GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
    Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Interaction of GLUT1 and FOXM1 Leads to a Poor Prognosis in Colorectal Cancer.
    Kuai XY; Lei ZY; Liu XS; Shao XY
    Anticancer Agents Med Chem; 2020; 20(8):941-950. PubMed ID: 32188390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.
    Goos JA; de Cuba EM; Coupé VM; Diosdado B; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-Van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ;
    Ann Surg; 2016 Jan; 263(1):138-45. PubMed ID: 25563886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
    Sakashita M; Aoyama N; Minami R; Maekawa S; Kuroda K; Shirasaka D; Ichihara T; Kuroda Y; Maeda S; Kasuga M
    Eur J Cancer; 2001 Jan; 37(2):204-9. PubMed ID: 11166147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miR-193a-5p correlates with lymph node metastasis and poor prognosis in colorectal cancer.
    Zhang P; Ji DB; Han HB; Shi YF; Du CZ; Gu J
    World J Gastroenterol; 2014 Sep; 20(34):12241-8. PubMed ID: 25232258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.
    Krzeslak A; Wojcik-Krowiranda K; Forma E; Jozwiak P; Romanowicz H; Bienkiewicz A; Brys M
    Pathol Oncol Res; 2012 Jul; 18(3):721-8. PubMed ID: 22270867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLUT1 gene is a potential hypoxic marker in colorectal cancer patients.
    Chung FY; Huang MY; Yeh CS; Chang HJ; Cheng TL; Yen LC; Wang JY; Lin SR
    BMC Cancer; 2009 Jul; 9():241. PubMed ID: 19619276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.
    Hong R; Lim SC
    World J Gastroenterol; 2012 Jan; 18(2):168-74. PubMed ID: 22253523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
    Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
    Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
    Li B; Kang H; Xiao Y; Du Y; Xiao Y; Song G; Zhang Y; Guo Y; Yang F; He F; Yang S
    Oncogene; 2022 Mar; 41(13):1882-1894. PubMed ID: 35149838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
    Gao JY; Song BR; Peng JJ; Lu YM
    World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.
    Maki Y; Soh J; Ichimura K; Shien K; Furukawa M; Muraoka T; Tanaka N; Ueno T; Yamamoto H; Asano H; Tsukuda K; Toyooka S; Miyoshi S
    Oncol Rep; 2013 Jan; 29(1):133-40. PubMed ID: 23076555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma.
    Ibrahiem AT; Refat S; Elnaghi K; Emarah Z; Nagib RM
    Indian J Pathol Microbiol; 2024 Jul; 67(3):518-524. PubMed ID: 38394402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.